Health Trials

Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction

ConditionsAnterior Cruciate Ligament TearAnterior Cruciate Ligament InjuriesAnterior Cruciate Ligament Rupture
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-40
SponsorThe Methodist Hospital Research Institute

About this trial

The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.

Eligibility criteria

Qualifiers

Patients of the IRB approved surgeon(s) undergoing ACL reconstruction with bone-to-bone (BTB) autograft

Patients aged between 18-40 years old at the time of surgery

Disqualifiers

Patients undergoing ACL reconstruction with any other type of autograft or allograft other than BTB

Patients younger than 18 years old or older than 40 years old

Patients undergoing meniscal root repair or any other repair that changes their weight-bearing status

Patients with a history of substance abuse

Trial design

Treatments tested in this trial

  • Intraosseous Morphine

Treatment groups

84 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The Methodist Hospital Research Institute

Lead sponsor

Source ClinicalTrials.gov